Search results
UBS Group AG Has $167.76 Million Stock Holdings in Novartis AG (NYSE:NVS)
ETF DAILY NEWS· 6 days agoUBS Group AG trimmed its stake in shares of Novartis AG (NYSE:NVS – Free Report) by 9.9% during the fourth quarter, according to its ...
Level Four Advisory Services LLC Cuts Stock Position in Novartis AG (NYSE:NVS)
ETF DAILY NEWS· 7 days agoLevel Four Advisory Services LLC trimmed its holdings in shares of Novartis AG (NYSE:NVS – Free Report) by 5.9% during the 4th quarter, according to the ...
Major drug companies caught up in Cencora data loss
The Register· 5 hours agoThe $250-billion firm – formerly known as AmerisourceBergen – partners with some of the largest pharma dealers, including GlaxoSmithKline, Novartis,...
Exploring Three Swiss Dividend Stocks With Yields Up To 4.6%
Simply Wall St. via Yahoo Finance· 4 hours agoThe Switzerland market recently displayed a downturn, influenced by ongoing concerns about U.S....
After UnitedHealth Cyberattack, Drug Distributor Cencora Notifies Americans' Health Information...
Benzinga via AOL· 3 days agoU.S. drug wholesaler Cencora Inc (NYSE:COR), formerly AmerisourceBergen, is notifying affected...
Ambivalent about big M&A, biotech Cytokinetics makes moves to raise $1 billion - San Francisco...
The Business Journals· 4 days agoNovartis AG, Johnson & Johnson and AstraZeneca have been reported since the start of the year to be...
GSK’s New Vaccine Kept the Boss in Her Job — and an Activist at Bay
Bloomberg via Yahoo Finance· 6 days ago(Bloomberg) -- When Elliott Investment Management came calling for the ouster of Emma Walmsley, the...
Boston radiopharmaceuticals startup inks deal worth up to $1.16B with Lilly - Boston Business...
The Business Journals· 6 days agoA Boston radiopharmaceuticals startup that is already backed by three Big Pharma companies now has a...
Exploring Swiss Dividend Stocks In May 2024
Simply Wall St. via Yahoo Finance· 3 days agoThe Switzerland market displayed resilience, closing slightly up on Thursday amidst a backdrop of mixed corporate updates and European economic data. The...
Biogen (BIIB) to Buy HI-Bio to Expand Rare Disease Pipeline
Zacks via Yahoo Finance· 4 days agoMorphoSys AG originally developed felzartamab for treating multiple myeloma. MorphoSys AG is due to...